Annovis Bio - ANVS Quarterly Revenue Growth

Symbol and logo of brand Annovis Bio (ANVS)

Annovis Bio, Inc. (ANVS) experiences volatility driven by a high dependence on the outcomes of clinical trials for Parkinson's and Alzheimer's disease drugs, where 0.00 represents the current metric level. The quarterly revenue growth rate reflects the impact of this resource concentration. Robotic screening and AI are accelerating the discovery of formulas, while patents on protein inhibition create a significant barrier to entry for competitors in the field of neuromedicine.

ANVS Annovis Bio Corporation Quarterly Revenue Growth Rate (07/04/2022 - 11/21/2026)

Metric breakdowns and analytics for Annovis Bio Inc (ANVS)

- stock price and consensus target price:
Fundamental valuation:annovisbio.com (ANVS)
Manufactured products of Annovis Bio

Quarterly revenue growth measures the dynamics of cash inflows relative to the previous period, allowing investors to assess the business scaling pace and the operational resilience of the issuer between reporting dates. When analyzing the quarterly revenue growth chart, it should be noted that for Annovis Bio, Inc. (ANVS), revenue development depends directly on the success of clinical trials for drugs targeting neurodegenerative diseases and the effectiveness of the patent protection for their software.

Competitor analysis

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|AMLX: Quarterly Revenue Growth|TRVI: Sales Change QoQ|Revenue Growth QoQ Praxis Medicines|Quarterly Revenue Growth Rate Anavex AVXL|Revenue Growth QoQ CeriBell Corp (CBLL)|Sales Change QoQ PRTA|Quarterly Revenue Growth ALEC (Alector)|Annexon (ANNX) - Quarterly Revenue Growth Rate|OMER - Revenue Growth QoQ|NGNE (Neurogene) - Sales Growth QoQ|ACIU: Quarterly Revenue Growth|VYGR - Quarterly Sales Growth Rate|Revenue Growth QoQ Neumora Therapeutics, Inc.|Sales Growth QoQ SCLX (Scilex)|Quarterly Sales Growth TVGN (Tevogen Bio)|Quarterly Revenue Growth Alpha Cognition Inc (ACOG)|Quarterly Revenue Growth CGTX (cogrx.com)|Quarterly Sales Growth Rate Inhibikase Pharma (IKT)|SAVA: Quarterly Sales Growth|Quarterly Sales Growth Rate Assertio ASRT|COYA (coyatherapeutics.com) - Quarterly Sales Growth|Sales Growth QoQ VTGN|OVID (Ovid Therapeutics) - Quarterly Revenue Growth|Acumen Pharmaceuticals, Inc (ABOS) - Quarterly Sales Growth Rate|Revenue Growth QoQ CervoMed, Inc. (CRVO)|ATHE - Quarterly Revenue Growth Rate|Quarterly Revenue Growth CLNN (Clene Inc.)|Quarterly Sales Growth Rate PepGen Inc. (PEPG)|JUNS - Revenue Growth QoQ|Quarterly Revenue Growth Rate Relmada Corp|GRCE (Grace Therapeutics) - Quarterly Sales Growth|Quarterly Revenue Growth Rate Firefly Neuroscience (AIFF)|Quarterly Sales Growth KLTO|NRSN: Quarterly Revenue Increase|Revenue Growth QoQ Reviva Pharmaceuticals Holdings (RVPH)|Quarterly Sales Growth MetaVia, Inc. MTVA|Revenue Growth QoQ NeurAxis NRXS|HSDT: Sales Growth QoQ|passagebio.com - Quarterly Revenue Growth|NEUP - Quarterly Revenue Growth|Minerva Neurosciences Corp (NERV) - Revenue Growth QoQ|Revenue Dynamics QoQ ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Quarterly Revenue Growth|Sales Growth QoQ ALZN (Alzamend Neuro)|Revenue Growth QoQ Cyclerion Therapeutics Inc. (CYCN)|Quarterly Revenue Growth Protagenic Therapeutics, Inc. (PTIX)|Quarterly Revenue Growth KTTA (Pasithea Therapeutics Corp)|CRGT - Quarterly Sales Growth|ATXI - Revenue Growth QoQ|BCLI: Revenue Growth QoQ|Cara Therapeutics (CARA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Chromocell Therapeutics Corp (CHRO)|Quarterly Sales Growth ELYM|Quarterly Revenue Growth Rate intracellulartherapies.com ITCI|Revenue Growth QoQ Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Quarterly Revenue Increase|Revenue Growth QoQ NKGen NKGN|Quarterly Revenue Growth NeuroBo Pharmaceuticals Inc NRBO|SAGE: Quarterly Sales Growth|Quarterly Sales Growth Rate Synaptogenix, Inc SNPX|TRVN: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ